Nature Communications (Oct 2024)

Enhanced Staphylococcus aureus protection by uncoupling of the α-toxin-ADAM10 interaction during murine neonatal vaccination

  • Kelly L. Tomaszewski,
  • Meagan Blanchard,
  • Reuben Olaniyi,
  • Hannah R. Brenton,
  • Samantha Hayes,
  • Farheen Fatma,
  • Gaya K. Amarasinghe,
  • Byoung-Kyu Cho,
  • Young Ah Goo,
  • Andrea C. DeDent,
  • Stephanie A. Fritz,
  • Juliane Bubeck Wardenburg

DOI
https://doi.org/10.1038/s41467-024-52714-7
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 14

Abstract

Read online

Abstract Staphylococcus aureus remains a leading global cause of bacterial infection-associated mortality and has eluded prior vaccine development efforts. S. aureus α-toxin (Hla) is an essential virulence factor in disease, impairing the T cell response to infection. The anti-Hla antibody response is a correlate of human protective immunity. Here we observe that this response is limited early in human life and design a vaccine strategy to elicit immune protection against Hla in a neonatal mice. By targeted disruption of the interaction of Hla with its receptor ADAM10, we identify a vaccine antigen (Hla H35L/R66C/E70C, HlaHRE) that elicits an ~100-fold increase in the neutralizing anti-Hla response. Immunization with HlaHRE enhances the T follicular helper (TFH) cell response to S. aureus infection, correlating with the magnitude of the neutralizing anti-toxin response and disease protection. Furthermore, maternal HlaHRE immunization confers protection to offspring. Together, these findings illuminate a path for S. aureus vaccine development at the maternal-infant interface.